Evaluating the Necrotising Enterocolitis Market: Global Strategies for Neonatal Care, Emerging Therapeutics, and Diagnostic Advancements in Preterm Infants
The high mortality and morbidity associated with Necrotising Enterocolitis (NEC) position the Necrotising Enterocolitis Market as a critical area of focus within neonatology and pediatric care. NEC is a devastating gastrointestinal disease primarily affecting preterm infants, characterized by intestinal inflammation and necrosis. The market growth is driven by the increasing global birth rate of preterm babies, coupled with advancements in neonatal intensive care unit (NICU) capabilities that allow smaller, sicker infants to survive, yet remain susceptible to NEC. Current management predominantly involves supportive care, including bowel rest and aggressive antibiotics, with surgery required for advanced cases. The significant unmet clinical need for effective preventive and non-surgical therapeutic agents is the major force propelling research and development. This includes the exploration of specialized feeding regimens, such as donor milk, and targeted probiotic administration…